Nalaganje...
Physician experiences with sodium-glucose cotransporter (SGLT2) inhibitors, a new class of medications in type 2 diabetes, and adverse effects
AIM: The primary aim of our study is to identify physicians who have witnessed a complication attributed to sodium-glucose cotransporter (SGLT2) inhibitors. The secondary aim is to determine the type, severity, and setting of the event (inpatient versus outpatient). BACKGROUND: Diabetes is an increa...
Shranjeno v:
| izdano v: | Prim Health Care Res Dev |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Cambridge University Press
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6567894/ https://ncbi.nlm.nih.gov/pubmed/30032729 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1017/S1463423618000476 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|